IMPORTANCE Little research has focused on very low-volume surgery, especially in the context of decreasing vascular surgery volume with the adoption of endovascular procedures.
S ince the first report of a volume-outcome relationship by Luft et al 1 in 1979 , considerable evidence that supports the positive association between facility and surgeon volume and surgical outcomes of patients has been generated by researchers. [2] [3] [4] [5] In the early 2000s, the Leapfrog group, a large coalition of health care purchasers, initiated the establishment of evidence-based referral for selected surgical procedures, during which minimum facility and surgeon volume standards were recommended. 6, 7 Since then, population-based studies have suggested the value of regionalization of surgical care in the United States, [8] [9] [10] [11] and volume standards are being planned to limit procedures performed by low-volume surgeons or facilities. 12 In vascular surgery, the volume-outcome relationship has been previously documented 10 for abdominal aortic aneurysm repairs and carotid endarterectomy (CEA). However, there has been a decrease in the number of open abdominal aortic aneurysm repair (OAR) and CEA procedures performed in the past 2 decades [13] [14] [15] owing to the advent of less-invasive endovascular aneurysm repair and carotid stenting. 16, 17 These changes might have important effects on surgeon volumes. While medical practice has adopted these guidelines in certain settings and encouraged regionalization to highervolume surgeons, low-volume surgeons continue to practice in other settings. In fact, the presence of very low-volume cardiologist practice, associated with higher case complications, including mortality, was one of the most notable findings in our previous work evaluating the real-world use of implantable defibrillators. 18 To our knowledge, little research has focused on very low-volume surgery, in large part because currently available data sources are based on multicenter or Medicare data that provide inaccurate information related to individual surgeon volume owing to incomplete recording or selection bias. In this study, we used a comprehensive state-level database to evaluate the practice of 1 or fewer procedures in OAR and CEA per year in a time of declining volume of open vascular operations and to determine the effect of this practice on perioperative outcomes.
Methods
The present observational cohort study used the New York State Department of Health Statewide Planning and Research Cooperative System, an all-age-group, all-payer database that collects patient and treatment information for every hospital discharge in New York. Each surgeon has a unique identifier to allow information collection regarding the specific surgeon over time in the database, irrespective of the hospital where the surgeon practiced. This study was approved by the Weill Cornell Medical College Institutional Review Board. Informed consent was waived because all patient data were obtained through a deidentified statewide database.
Cohort Selection and Surgeon Volume and Specialty
We used International Classification of Diseases, Ninth Revision, Clinical Modification diagnosis and procedure codes to identify patients undergoing OAR and CEA between 2000 and 2014 (eTable 1 in the Supplement). [19] [20] [21] [22] Only elective procedures were included, as physicians may not have been able to transfer urgent or emergent cases. To ensure homogeneous comparisons, we excluded patients who underwent OAR and a concurrent procedure for aorta dissection or thoracic aneurysm, visceral or renal bypass, endovascular aneurysm repair, or major cardiac surgery (eg, valve surgery or coronary artery procedures). For the same purpose, those who underwent CEA and a concurrent carotid stenting or major cardiac surgery were also excluded. Surgeon volume was calculated for each year in which the surgeon performed at least 1 operation (indicating that they were in active practice in New York during that year). Average annual surgeon volume was obtained by dividing the total designated (OAR or CEA) procedures performed by the total number of years in which the surgeon performed at least 1 procedure. Those who performed 1 or less procedures every year on average were classified as very low-volume surgeons. In the calculation of average annual volume, procedures performed concurrent to other operations and during both elective and emergent/urgent admissions were included.
Surgeon specialties were determined using a revised algorithm based on the distribution of their procedure types, as previously described, 23, 24 and were grouped as vascular, cardiac, and general/other (including neurosurgeons) (eTable 1 in the Supplement). Surgeons whose practices comprised more than 75% vascular surgery were classified as vascular surgeons. Among nonvascular surgeons, those whose practices comprised more than 20% cardiac surgery were classified as cardiac surgeons. All others were defined as general/other surgeons.
Patient Characteristics and Outcomes
Patient characteristics included age, sex, race/ethnicity, primary insurance payer, and comorbidities. Major comorbidities were identified using algorithms validated by Elixhauser. 25 Institution-related characteristics included location of hospital (New York City or other) and hospital volume of the designated procedure. Average annual hospital volume of the specific procedure was calculated, and hospitals were categorized into tertiles accordingly. The primary outcome of the study was inpatient safety, including perioperative mortality, acute myocardial infarction (AMI), and stroke. Other outcomes included in-hospital sepsis and shock, length of stay (LOS), total charges adjusted to 2014 US dollars, 26 and 30-day readmission into hospital. We identified AMI and stroke using present-on-admission indicators with algorithms, described in previous studies. 27,28 Prolonged LOS and excessive charges were defined as more than the 75th percentile. Patients who died in hospital during the index admission or were discharged during the last month of the study period (December 2014) were excluded from readmission analysis.
Statistical Analyses
Percentages of very low-volume surgeons and percentages of patients treated by these surgeons were evaluated over the study period for both procedures. Baseline patient, surgeon, and institutional characteristics and outcomes were examined among patients treated by very low-volume surgeons and those treated by higher-volume surgeons. To compare differences in baseline characteristics and unadjusted outcomes between the groups, χ 2 tests were used for categorical variables, t tests for age, and Wilcoxon rank sum tests for LOS and hospital charges.
In adjusted analysis, we used 3 models to assess differences in outcomes between patients treated by very lowvolume surgeons and those treated by higher-volume surgeons for OAR and CEA. Model 1 used logistic regression and only adjusted for patient characteristics, including age, sex, race/ethnicity, insurance status, procedure year, and major comorbidities. Model 2 and model 3 used a generalized linear mixed model to account for surgeon and hospital clustering as random effects. Model 2 additionally adjusted for surgeon specialty and accounted for surgeon clustering. Model 3 was a fully adjusted model, controlling for all patient, surgeon, and facility characteristics and accounting for both surgeon and hospital clustering. A missing category was created for race/ ethnicity in adjusted analysis. Sensitivity analysis was performed after excluding suspicious surgeons who were present in the database for only 1 year and very low-volume surgeons who performed 5 or more procedures in a particular year. This was to minimize the possibility of including surgeons who practiced in multiple states and only performed few operations in New York. Sensitivity analysis was also performed with surgeons performing 3 or less procedures per year on average classified as very low volume to account for possible coding errors related to the designated procedures.
Subgroup analyses were conducted to compare outcomes of patients treated by very low-volume surgeons with those treated by surgeons in low-volume (but performed more than 1 procedure per year), medium-volume, and highvolume tertiles, determined by surgeons' average annual volume of the specific procedure. All analyses were performed using SAS version 9.3 (SAS Institute). All P values were 2-sided, and a P value < .05 was regarded as significant.
Results
A total of 614 surgeons performed OAR and 1071 performed CEA in New York during the study period. Of these, 318 surgeons (51.8%) who performed OAR and 512 surgeons (47.8%) who performed CEA were low-volume surgeons. They performed 667 of 8781 OAR procedures (7.6%) and 904 of 68 896 CEA procedures (1.3%), respectively. Very low-volume surgeons were less likely to be vascular surgeons compared with higher-volume surgeons for both OAR (23.9% vs 63.9%; P < .001) and CEA (14.6% vs 51.7%; P < .001) (Figure 1) . 
Open Aneurysm Repair
Among patients undergoing OAR, those treated by very lowvolume surgeons were younger (mean age, 70.1 vs 71.8 years; P < .001), more likely to have Medicaid (5.1% vs 1.8%; P < .001), and less likely to be white (84.5% vs 90.7%; P < .001) or have 2 or more comorbidities (64.6% vs 68.4%; P = .07) compared with patients treated by higher-volume surgeons ( Table 1) . A larger proportion of procedures performed by very low-volume surgeons happened in New York City (35.4% vs 21.8%; P < .001) and in low-volume hospitals (66.3% vs 30.6%; P < .001).
Patients whose OAR was performed by very low-volume surgeons had higher postoperative mortality (6.7% vs 3.5%; P < .001) as well as higher risks of sepsis or shock (5.7% vs 3.7%; P = .008) and 30-day readmission (16.0% vs 13.6%; P =.10) ( Table 2) . Those treated by very low-volume surgeons were also more likely to have prolonged LOS (ie, ≥9 days; 39.3% vs 30.1%; P < .001) and higher hospital charges (median cost, $54 660 vs $49 156; P < .001). 
Carotid Endarterectomy
Among patients undergoing CEA, those treated by very lowvolume surgeons were less likely to be white (81.3% vs 89.8%; P < .001) and to have 2 or more comorbidities (59.8% vs 63.3%; P = .02) compared with patients treated by higher-volume surgeons (Table 1) . Those treated by very low-volume surgeons were more likely to have Medicaid insurance (5.8% vs 2.9%; P < .001). A larger proportion of procedures performed by very low-volume surgeons happened in New York City (32.6% vs 20.8%; P < .001) and in low-volume hospitals (53.4% vs 33.3%; P < .001).
Mortality and occurrence of sepsis or shock following CEA procedures were low in both groups (<1%). Patients whose CEA was performed by very low-volume surgeons had higher risks experiencing postoperative AMI (1.5% vs 0.5%; P < .001), stroke (3.5% vs 2.1%; P = .003), and 30-day readmission (11.5% vs 8.5%; P = .002) ( Table 2 ). This group of patients also had longer LOS (median, 2 vs 1 day; P < .001) and higher hospital charges (median cost, $15 290 vs $16 349; P < .001).
After adjusting for all patient, surgeon, and facility characteristics, patients treated by very low-volume surgeons had 1.8-fold higher odds of experiencing AMI (OR, 1.83; 95% CI, 1.03-3.26) and stroke (OR, 1.78; 95% CI, 1.21-2.62) than those treated by higher-volume surgeons ( Figure 3B ) (eTable 2intheSupplement). Patients treated by very low-volume surgeons were also more likely to have excessive charges (OR, 1.28; 95% CI, 1.01-1.62) and 30-day readmission (OR, 1.30; 95% CI, 1.04-1.62).
Sensitivity and Subgroup Analyses
Results from sensitivity analysis, excluding suspicious surgeons and redefining very low volume as performing 3 or less procedures per year on average, were both consistent with the main analysis (eTables 3 and 4 in the Supplement). In subgroup analyses, the proportion of vascular surgeons increased with increasing surgeon volume for both OAR and CEA (eFigure in the Supplement). When fully adjusted, patients treated by very low-volume surgeons had worse outcomes compared with those treated by low-volume, medium-volume, and high-volume surgeons (eTable 5 in the Supplement). Patients undergoing OAR performed by very low-volume surgeons were more likely to have higher mortality and more frequent prolonged LOS and 30-day readmission, even compared with those treated by surgeons in the lowest volume tertile. Similar results were observed for outcomes following CEA, including AMI, stroke, hospital charges, and 30-day readmission. 
Discussion
We found that the practice of very low-volume surgeons performing OAR and CEA has declined in New York from 2000 to 2014. Very low-volume surgeons were more likely to be cardiac or general surgeons rather than vascular surgeons. The existence of very low-volume practice was associated with worse clinical outcomes as well as economic consequences, including higher charges, longer LOS, and more frequent readmissions. Our first major finding elucidated the persistence of very low-volume practice in open vascular surgery, with decreases in the number of very low-volume surgeons and the number of OAR and CEA procedures they performed over time. As the use of endovascular procedures became more prevalent, the total cases of OAR and CEA have steadily decreased. [13] [14] [15] The reduction in the total share of open procedures may in turn lead to a decrease in the number of surgeons performing open procedures, especially the very low-volume ones, possibly owing to the more intense competition for limited cases. On the other hand, the current trend toward regionalization may have encouraged patients to seek higher-volume surgeons for OAR and CEA. 8, 29 While shrinking in absolute numbers over time, we found that very low-volume surgeons continued to exist and that a much larger proportion of them were nonvascular surgeons, in contrast with higher-volume surgeons. Previous studies have shown the collinearity of surgeon volume and degree of specialization in OAR and CEA. 24, 30 The presence of the large proportion of nonvascular surgeons among very low-volume surgeons may help explain the continuing existence of this practice.
Second, one of the most noteworthy differences in characteristics between patients treated by very low-volume surgeons and those treated by higher-volume surgeons was that the former tended to be younger and generally healthier. Previous studies have also shown that patients treated electively with OAR and CEA by lower-volume surgeons were younger and had fewer comorbidities than those treated by higher-volume surgeons. 4, 23 This might be related to the fact that operating on patients of older age and worse general health status is more challenging both in technical aspects and postoperative care, especially in high-risk procedures; low-volume surgeons might be reluctant to operate on those patients and seek referral. Patients treated by very low-volume surgeons had overall fewer comorbidities at the time of surgery. Furthermore, this group of patients were also more likely to be nonwhite or insured by Medicaid. Therefore, it is reasonable to speculate that those treated by very low-volume surgeons were more likely to be socioeconomically disadvantaged. As has been shown before, disparity exists in access to surgical care, where nonwhite patients more frequently received cardiovascular operations in low-volume hospitals. 31 The presence of disparity in access to surgical care at the surgeon level is likely closely associated with hospital-level disparity and may contribute to the persistence of very low-volume surgeon practice. Third, and most importantly, the practice of 1 or fewer annual procedures was adversely associated with postoperative mortality and complications following OAR and CEA. The association between volume and operative mortality and complications in elective OAR and CEA has long been recognized. 4, 23, 24, [32] [33] [34] In a systemic review summarizing volume-outcome relationship in various vascular procedures, 10 it was noted that the association between individual surgeon caseload and outcome was more important for elective OAR and CEA. Significantly, in our study, we found that the inferiority of surgical outcomes associated with very low-volume practice persisted even when compared with other surgeons in the lowest volume tertile and after adjusting for all patient risk factors, surgeon specialty, and facility characteristics. Moreover, our study showed that the practice of 1 or fewer annual procedures was associated with greater resource use, including longer LOS, higher hospital charges, and more frequent 30-day readmissions. These associations were pronounced when only adjusting for patient-level characteristics and persisted but were mitigated when further accounting for surgeon and hospital characteristics and clusters. Three studies since 2010 have illustrated the effect of higher hospital volume on reducing health care resource use associated with OAR and CEA. 32, 35, 36 Two of these studies further demonstrated that lower resource use associated with highervolume surgeons was independent of hospital volume. 32, 36 In addition to the effect of hospitals, surgeons likely have also played critical roles in reducing health care resource use, as surgical complications have been highlighted as the most significant reason for readmission following surgery.
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Limitations
Our study had limitations. One limitation with using administrative data was the lack of clinical information regarding the complexity of surgery, such as aneurysm size and symptomatic status of patients who underwent CEA. Unmeasured confounding cannot be entirely ruled out in this case. However, as discussed earlier, because very low-volume surgeons were likely to be reluctant to operate on complex cases, current bias would be toward null. When counting surgeon volume of OAR and CEA, 8% of OAR procedures and 3% of CEA procedures were coded as secondary procedures, with principal procedures being cardiac procedures or tracheostomy. Because these procedures cannot be ascertained to have been performed by the same surgeon, they were not counted toward total OAR and CEA procedure volume. This may have led to misclassification of a few higher-volume surgeons into the very lowvolume group. Bias from the misclassification would also be toward null and would unlikely affect our conclusion. Finally, the generalizability of the conclusions drawn from the present study to nationwide needs to be viewed on a state-tostate basis. Despite the limitations, our study is robust, advancing knowledge in the volume-outcome relationship, with important policy implications. More research is needed to document this practice in various surgical settings to determine the scale of the problem of very low-volume practitioners in the entire interventional field. Our findings on surgeon practice of 1 or fewer cases per year in 2 major vascular operations indicates the need to eliminate this type of practice, to restrict the practice of these very low-volume surgeons or force referrals to higher-volume and specialized surgeons, and to improve disparity in access to high-quality care for all patients. Impressively, our study showed that more than 30% of this very low-volume practice occurred in New York City, a place where accessibility to high-volume practitioners should generally be higher, suggesting opportunities for future improvement.
Conclusions
Open abdominal aortic aneurysm repair and carotid endarterectomy performed by very low-volume surgeons resulted in worse postoperative outcomes and longer LOS. Although the percentage of very low-volume surgeons declined from 2000 to 2014, it remains concerning, given ready access to highervolume surgeons. Future research is needed to understand the existence of this practice pattern in other surgical fields. Efforts to eliminate this practice pattern are warranted to ensure high-quality care for all patients. 
